Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lovrich

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Infection and Immunity|October 1, 1991
Depletion of complement and effects on passive transfer of resistance to infection with Borrelia burgdorferiJ L Schmitz, S D Lovrich, S M Callister, et al.
Journal of Clinical Microbiology|May 31, 2002
Reassessment of a midwestern Lyme disease focus for Borrelia burgdorferi and the human granulocytic ehrlichiosis agentCraig A Jackson, Steven D Lovrich, William A Agger, et al.
Clinical and Diagnostic Laboratory Immunology|July 11, 2003
C-terminal region of outer surface protein C binds borreliacidal antibodies in sera from patients with Lyme diseaseDean A Jobe, Steven D Lovrich, Ronald F Schell, et al.
Endeavour|January 1, 1994
Lyme disease: laboratory diagnosis and serologic testingS M Callister, R F Schell, S D Lovrich, et al.
Infection and Immunity|October 1, 1993
Seroprotective groups among isolates of Borrelia burgdorferiS D Lovrich, S M Callister, L C Lim, et al.
Diagnostic Microbiology and Infectious Disease|November 12, 2022
Clinical evaluation of a Borrelia modified two-tiered testing (MTTT) shows increased early sensitivity for Borrelia burgdorferi but not other endemic Borrelia species in a high incidence region for Lyme disease in WisconsinArick P Sabin, Brooklynn P Scholze, Steven D Lovrich, et al.
Clinical Lymphoma & Myeloma|October 28, 2009
Emergence of chronic myelogenous leukemia from a background of myeloproliferative disorder: JAK2V617F as a potential risk factor for BCR-ABL translocationSai Ravi Kiran Pingali, Michelle A Mathiason, Steven D Lovrich, et al.
Microbiology (Reading, England)|November 24, 2012
OmpR regulation of the uropathogenic Escherichia coli fimB gene in an acidic/high osmolality environmentAnn E Rentschler, Steven D Lovrich, Robert Fitton, et al.
Clinical and Vaccine Immunology : CVI|April 22, 2011
Rapid decline of OspC borreliacidal antibodies following treatment of patients with early Lyme diseaseDean A Jobe, Todd J Kowalski, Marissa Bloemke, et al.
Clinical and Diagnostic Laboratory Immunology|July 1, 1996
Sensitivity and specificity of the borreliacidal-antibody test during early Lyme disease: a "gold standard"?S M Callister, D A Jobe, R F Schell, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Infection and Immunity|October 1, 1991
Depletion of complement and effects on passive transfer of resistance to infection with Borrelia burgdorferiJ L Schmitz, S D Lovrich, S M Callister, et al.
Journal of Clinical Microbiology|May 31, 2002
Reassessment of a midwestern Lyme disease focus for Borrelia burgdorferi and the human granulocytic ehrlichiosis agentCraig A Jackson, Steven D Lovrich, William A Agger, et al.
Clinical and Diagnostic Laboratory Immunology|July 11, 2003
C-terminal region of outer surface protein C binds borreliacidal antibodies in sera from patients with Lyme diseaseDean A Jobe, Steven D Lovrich, Ronald F Schell, et al.
Endeavour|January 1, 1994
Lyme disease: laboratory diagnosis and serologic testingS M Callister, R F Schell, S D Lovrich, et al.
Infection and Immunity|October 1, 1993
Seroprotective groups among isolates of Borrelia burgdorferiS D Lovrich, S M Callister, L C Lim, et al.
Diagnostic Microbiology and Infectious Disease|November 12, 2022
Clinical evaluation of a Borrelia modified two-tiered testing (MTTT) shows increased early sensitivity for Borrelia burgdorferi but not other endemic Borrelia species in a high incidence region for Lyme disease in WisconsinArick P Sabin, Brooklynn P Scholze, Steven D Lovrich, et al.
Clinical Lymphoma & Myeloma|October 28, 2009
Emergence of chronic myelogenous leukemia from a background of myeloproliferative disorder: JAK2V617F as a potential risk factor for BCR-ABL translocationSai Ravi Kiran Pingali, Michelle A Mathiason, Steven D Lovrich, et al.
Microbiology (Reading, England)|November 24, 2012
OmpR regulation of the uropathogenic Escherichia coli fimB gene in an acidic/high osmolality environmentAnn E Rentschler, Steven D Lovrich, Robert Fitton, et al.
Clinical and Vaccine Immunology : CVI|April 22, 2011
Rapid decline of OspC borreliacidal antibodies following treatment of patients with early Lyme diseaseDean A Jobe, Todd J Kowalski, Marissa Bloemke, et al.
Clinical and Diagnostic Laboratory Immunology|July 1, 1996
Sensitivity and specificity of the borreliacidal-antibody test during early Lyme disease: a "gold standard"?S M Callister, D A Jobe, R F Schell, et al.
Pageof 6